Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brian Michael Alexander, M.D.

Concepts (329)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glioblastoma27201834823.590 Why?
Brain Neoplasms42201890313.130 Why?
Clinical Trials, Phase II as Topic420176291.510 Why?
Meningioma8201712181.140 Why?
Meningeal Neoplasms8201712481.120 Why?
Dacarbazine420155590.990 Why?
Radiosurgery9201813420.980 Why?
Clinical Trials as Topic7201880020.930 Why?
Salvage Therapy5201712640.860 Why?
Cranial Irradiation620173900.850 Why?
Endpoint Determination420185900.790 Why?
Antineoplastic Agents, Alkylating220156170.750 Why?
Bayes Theorem6201723300.710 Why?
Dictionaries as Topic12018110.640 Why?
DNA Repair4201620450.610 Why?
Glioma5201734550.580 Why?
Neoplasm Recurrence, Local9201792800.560 Why?
Research Design6201761800.560 Why?
Randomized Controlled Trials as Topic52017102090.510 Why?
Clinical Trials, Phase III as Topic220178570.510 Why?
Tumor Burden6201518930.480 Why?
Kaplan-Meier Estimate7201864840.450 Why?
Prognosis242018296250.420 Why?
Small Cell Lung Carcinoma120174230.410 Why?
Radiotherapy, Adjuvant3201417840.410 Why?
Proportional Hazards Models62018124630.400 Why?
Radiation-Sensitizing Agents120133500.370 Why?
Isocitrate Dehydrogenase420169380.370 Why?
Breast Neoplasms102018210120.370 Why?
Fanconi Anemia Complementation Group D2 Protein120111460.370 Why?
Survival Rate152018127250.370 Why?
Radiotherapy, Intensity-Modulated320158010.360 Why?
Lung Neoplasms92018133800.360 Why?
Steroids120159290.360 Why?
Carcinoma, Non-Small-Cell Lung6201853150.350 Why?
Information Dissemination1201811260.340 Why?
Survival Analysis42018100900.340 Why?
Patient Participation1201814440.320 Why?
Decision Making3201839290.300 Why?
Mastectomy, Simple12007230.290 Why?
Thalidomide120128850.280 Why?
Angiogenesis Inhibitors2201720470.280 Why?
Seroma12007750.280 Why?
Humans8320187615040.280 Why?
Combined Modality Therapy7201885290.280 Why?
Anticonvulsants1201519060.250 Why?
Patient Selection1201842440.250 Why?
Diagnosis120061570.250 Why?
Immunotherapy2201846520.250 Why?
Whole-Body Irradiation120054330.230 Why?
Follow-Up Studies132018391060.230 Why?
Middle Aged3920182208950.230 Why?
Health Care Costs1201732420.230 Why?
Cell Cycle1201129320.220 Why?
Neoplasm Staging72015111210.210 Why?
Neoplasm, Residual3201810080.210 Why?
Melanoma4201857090.210 Why?
Adult3320182211770.200 Why?
Adaptor Proteins, Signal Transducing2201628980.200 Why?
Comparative Genomic Hybridization420164730.200 Why?
Aged, 80 and over202017589760.200 Why?
Female4520183926440.200 Why?
Aged3120181692890.190 Why?
Radiation Injuries3201811890.190 Why?
Esophageal Neoplasms1201116540.190 Why?
Prostate-Specific Antigen2200824690.190 Why?
Neoadjuvant Therapy2201128270.180 Why?
Male3920183608040.180 Why?
Retrospective Studies182018806360.170 Why?
Antineoplastic Agents52018136390.170 Why?
Radiotherapy Dosage4201528980.170 Why?
Disease-Free Survival5201868140.170 Why?
Carcinoma, Ductal, Breast1200710850.170 Why?
Karnofsky Performance Status320151660.160 Why?
Carcinoma1201023300.160 Why?
Terminology as Topic1200615300.160 Why?
Diagnostic Imaging1201335300.160 Why?
Propensity Score2201719130.160 Why?
Androgen Antagonists1200714100.160 Why?
DNA Copy Number Variations3201520200.150 Why?
Nuclear Proteins2201457960.150 Why?
Tumor Suppressor Protein p534201529170.150 Why?
DNA Modification Methylases120182100.140 Why?
Tumor Suppressor Proteins2201828030.140 Why?
Treatment Outcome132018646800.140 Why?
Receptors, Progesterone2201211290.140 Why?
Treatment Failure3201426450.140 Why?
SEER Program3201714500.130 Why?
DNA Repair Enzymes120183460.130 Why?
National Cancer Institute (U.S.)120172970.130 Why?
Health Planning120172300.130 Why?
Imidazolines12015180.130 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1200515510.130 Why?
Radiotherapy Planning, Computer-Assisted2201516610.130 Why?
Analysis of Variance4201462280.130 Why?
Algorithms22016140310.130 Why?
Receptor, erbB-24201725570.130 Why?
Recurrence5201284650.120 Why?
Pilot Projects3201886310.120 Why?
Rhabdoid Tumor120172100.120 Why?
MAP Kinase Kinase Kinases120162550.120 Why?
Adenoma, Oxyphilic120161480.120 Why?
Skin Neoplasms1201458210.120 Why?
National Institutes of Health (U.S.)120187930.120 Why?
Health Priorities120173740.120 Why?
Mutation102017300520.120 Why?
Disease Progression52017135060.120 Why?
Neoplasms42017221700.120 Why?
Evidence-Based Medicine1200636880.120 Why?
Ubiquitin Thiolesterase120174550.110 Why?
Signal Transduction32017234450.110 Why?
Postoperative Care2201814680.110 Why?
Semantics120176010.110 Why?
Young Adult132017592430.110 Why?
Receptors, Estrogen2201222080.110 Why?
Chromosomes, Human, Pair 5120143860.110 Why?
Selection Bias120153590.110 Why?
Proto-Oncogene Proteins c-mdm2120153680.110 Why?
Morpholines120165810.110 Why?
Genital Neoplasms, Male12013680.110 Why?
Oligodendroglioma120142790.100 Why?
Magnetic Resonance Imaging92018364260.100 Why?
DNA Mutational Analysis3201641110.100 Why?
Radiotherapy3201614990.100 Why?
Aminopyridines120165730.100 Why?
Age Factors42015183950.100 Why?
Neoplasm Proteins2201536170.090 Why?
Cohort Studies42015414870.090 Why?
Adenocarcinoma3201863460.090 Why?
Radiation Pneumonitis120111020.090 Why?
Radiation Tolerance120134790.090 Why?
Methylenetetrahydrofolate Reductase (NADPH2)120112760.090 Why?
Liposarcoma120132890.090 Why?
Neurology120187800.090 Why?
Immunohistochemistry42016110760.090 Why?
Astrocytoma120147750.090 Why?
United States Food and Drug Administration1201816640.090 Why?
Protein Array Analysis120114000.090 Why?
Multiprotein Complexes1201611180.080 Why?
Poly(ADP-ribose) Polymerases120114260.080 Why?
Antineoplastic Combined Chemotherapy Protocols32018117420.080 Why?
MAP Kinase Signaling System1201614860.080 Why?
Benzhydryl Compounds120169160.080 Why?
Lymphocytes, Tumor-Infiltrating1201510920.080 Why?
Spinal Neoplasms120157160.080 Why?
Fatigue1201615520.080 Why?
Medically Uninsured120148360.080 Why?
Quinazolines1201513710.080 Why?
Movement1201514780.080 Why?
Proto-Oncogene Proteins p21(ras)1201617450.080 Why?
Contrast Media2201853110.080 Why?
Chromosome Aberrations1201417680.080 Why?
Prostatic Neoplasms22008111180.080 Why?
Adolescent72017883190.070 Why?
Image Enhancement1201828850.070 Why?
Pituitary Neoplasms1201613240.070 Why?
Cost of Illness1201719360.070 Why?
Neoplasms, Second Primary1201510520.070 Why?
TOR Serine-Threonine Kinases1201620570.070 Why?
Genes, BRCA1120117640.070 Why?
Piperidines1201516560.070 Why?
Proto-Oncogene Proteins B-raf1201620570.070 Why?
Phosphatidylinositol 3-Kinases1201628650.070 Why?
Predictive Value of Tests42014152660.070 Why?
Autophagy1201413260.070 Why?
Cell Lineage1201425550.060 Why?
Cell Transformation, Neoplastic1201428250.060 Why?
Neurosurgical Procedures1201520720.060 Why?
Molecular Targeted Therapy2201628110.060 Why?
Incidence42017213530.060 Why?
Time Factors32017399670.060 Why?
DNA Methylation1201843980.060 Why?
Uncertainty120087540.050 Why?
Disease Management1201425080.050 Why?
Pancreatic Neoplasms2201453680.050 Why?
Monomeric Clathrin Assembly Proteins12003240.050 Why?
Apoptosis2201694860.050 Why?
Carcinoma, Renal Cell1201831640.050 Why?
Xenograft Model Antitumor Assays3201636020.050 Why?
Drug Resistance, Neoplasm2201653050.050 Why?
Diagnostic Tests, Routine120087870.050 Why?
Prostatectomy2200818240.050 Why?
Preoperative Care1201122420.050 Why?
Sentinel Lymph Node Biopsy120077320.050 Why?
Chromosome Inversion120031200.050 Why?
Proto-Oncogenes120033210.050 Why?
Biomedical Research1201734290.050 Why?
Tumor Microenvironment1201538770.050 Why?
Insurance, Health1201424980.050 Why?
Chromosomes, Human, Pair 11120034100.050 Why?
Multivariate Analysis12015120590.050 Why?
Genetic Testing1201435370.050 Why?
Intracellular Signaling Peptides and Proteins1201128720.050 Why?
Genomics1201758210.050 Why?
T-Lymphocytes, Regulatory1201530800.050 Why?
DNA-Binding Proteins2201196060.040 Why?
Models, Statistical1201550790.040 Why?
Protein Kinase Inhibitors1201656710.040 Why?
Leukemia, Myeloid120036940.040 Why?
Sensitivity and Specificity32015146660.040 Why?
United States52018723340.040 Why?
PTEN Phosphohydrolase2201511150.040 Why?
Neoplasm Invasiveness1200735950.040 Why?
Lymph Nodes1201034660.040 Why?
Transplantation Conditioning1200515900.040 Why?
Bone Marrow Transplantation1200526930.040 Why?
Risk Factors52015742060.030 Why?
Eukaryotic Initiation Factors12016850.030 Why?
Polymorphism, Single Nucleotide22015159360.030 Why?
Carcinoma, Squamous Cell1201140260.030 Why?
Animals520161684590.030 Why?
Genome-Wide Association Study12015126900.030 Why?
Quality of Life12017133670.030 Why?
Hospitalization12015107230.030 Why?
Gene Expression Profiling3201694200.030 Why?
Epithelial Cells1200736730.030 Why?
Oximes120163030.030 Why?
Membrane Proteins1201178560.030 Why?
Lomustine12014600.030 Why?
Oncogene Proteins, Fusion1200316060.030 Why?
Immobilization120152290.030 Why?
Carmustine120141380.030 Why?
Ki-67 Antigen120166290.030 Why?
Brain22018271120.030 Why?
Caspase 3120167310.030 Why?
Exons2201423910.030 Why?
Sample Size120178410.030 Why?
Pyrimidinones120163850.030 Why?
Necrosis1201816110.030 Why?
Organs at Risk120153590.030 Why?
Drug Therapy120165030.030 Why?
Physician-Patient Relations1200632490.030 Why?
Reverse Transcriptase Polymerase Chain Reaction2201545750.030 Why?
Neoplasm Transplantation1201620160.030 Why?
High-Throughput Nucleotide Sequencing2201436390.020 Why?
Area Under Curve1201616380.020 Why?
Genomic Instability120167090.020 Why?
Immunoenzyme Techniques1201517050.020 Why?
Loss of Heterozygosity120146620.020 Why?
Class I Phosphatidylinositol 3-Kinases120168990.020 Why?
Gene Dosage1201612170.020 Why?
Cone-Beam Computed Tomography120154740.020 Why?
Mice, SCID1201626260.020 Why?
Genotype22016129900.020 Why?
Pyridones120168090.020 Why?
Sex Factors22015105520.020 Why?
Remission Induction1201623960.020 Why?
Imidazoles1201611800.020 Why?
Particle Accelerators120101740.020 Why?
Lymphatic Metastasis1201729150.020 Why?
DNA Helicases120148510.020 Why?
Genetic Markers1201526010.020 Why?
Decision Theory12008270.020 Why?
Germ-Line Mutation1201718580.020 Why?
Forecasting1201729280.020 Why?
Child, Preschool22015422300.020 Why?
Blotting, Western1201550350.020 Why?
Phosphoproteins1201624480.020 Why?
Proto-Oncogene Proteins c-akt1201624550.020 Why?
Thrombolytic Therapy1199620640.020 Why?
Hematopoietic Stem Cell Transplantation1200556710.020 Why?
Reproducibility of Results22015200980.020 Why?
Nomograms120082300.020 Why?
Educational Status1201425220.020 Why?
Health Services Needs and Demand1201414030.020 Why?
Drug Therapy, Combination1201663100.020 Why?
Medical Oncology1201723210.020 Why?
Likelihood Functions120089920.020 Why?
Phosphorylation1201683200.020 Why?
Odds Ratio1201796460.020 Why?
Cell Cycle Proteins1201634480.010 Why?
Coronary Angiography1199644710.010 Why?
Mice32016815250.010 Why?
Heterozygote1201127870.010 Why?
Early Detection of Cancer1201832010.010 Why?
Genetic Predisposition to Disease22015179040.010 Why?
Radiation Dosage1201119580.010 Why?
Transcription Factors12003121280.010 Why?
Carrier Proteins1201649360.010 Why?
Stomach120076960.010 Why?
Insurance Coverage1201419400.010 Why?
Child22015801530.010 Why?
Chromosome Breakage120031590.010 Why?
Poverty1201426980.010 Why?
Chemotherapy, Adjuvant1201135140.010 Why?
Cytogenetic Analysis120032700.010 Why?
Imaging, Three-Dimensional1201540630.010 Why?
Prospective Studies22017544250.010 Why?
Double-Blind Method12016123410.010 Why?
Kidney Neoplasms1201842490.010 Why?
CD8-Positive T-Lymphocytes1201545800.010 Why?
Intestine, Small1200712060.010 Why?
Image Processing, Computer-Assisted1201790000.010 Why?
Neoplasm Metastasis1201149150.010 Why?
Myeloid-Lymphoid Leukemia Protein120033050.010 Why?
RNA, Messenger12015127950.010 Why?
Risk1201196100.010 Why?
Gene Expression Regulation, Neoplastic1201585470.010 Why?
Logistic Models12014132550.010 Why?
DNA, Complementary1200319910.010 Why?
Diagnosis, Differential12014129740.010 Why?
Cell Line, Tumor12015169810.010 Why?
Cognition1201669900.010 Why?
Data Interpretation, Statistical1200826910.010 Why?
Histone-Lysine N-Methyltransferase120036820.010 Why?
Prevalence12015157320.010 Why?
Infant22015361920.010 Why?
Boston1201093260.010 Why?
Alternative Splicing1200310930.010 Why?
DNA, Neoplasm1200317450.010 Why?
In Situ Hybridization, Fluorescence1200325100.010 Why?
Phenotype12014165910.010 Why?
Cineangiography119961080.010 Why?
Feasibility Studies1200752470.010 Why?
Radiography1200769650.010 Why?
Myocardial Infarction11996114600.010 Why?
Disease Models, Animal12014182520.010 Why?
Chromosome Mapping1200346150.010 Why?
Polymerase Chain Reaction1200360750.010 Why?
Blood Flow Velocity1199613710.010 Why?
Acute Disease1200372370.010 Why?
Tomography, X-Ray Computed12015205700.010 Why?
Kidney1200770480.010 Why?
Base Sequence12003124410.010 Why?
Liver1200775290.010 Why?
Amino Acid Sequence12003134460.010 Why?
Molecular Sequence Data12003176350.010 Why?
Coronary Circulation1199615690.010 Why?
Hemodynamics1199641590.000 Why?
Alexander's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (329)
Explore
_
Co-Authors (116)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.